Top Story

Nicox, Bausch + Lomb restructure Vyzulta financial terms

March 16, 2018

Glaucoma Research Foundation awards $720,000 in research grants

March 15, 2018
Glaucoma Research Foundation is supporting 12 investigators at U.S. universities with $720,000 in research grants, according to a press release. The organization is…

BLOG: A stint on the iStent

March 14, 2018
It is estimated that 3.6 million cataract surgeries will be performed in the U.S. this year. Current estimates suggest more than 3 million Americans have glaucoma, and…

Insurance coverage of Vyzulta expands with Express Scripts

March 12, 2018
Express Scripts will begin covering Vyzulta under an agreement with Bausch + Lomb, according to a press release. Vyzulta (latanoprostene bunod ophthalmic solution…
More Headlines »

Medical Management of Glaucoma: Recent Approvals and Drugs Under Investigation

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the…
More »
Meeting News

Hydrus microstent yields lower IOP, rapid visual recovery

March 2, 2018
More »
Resource Centers


Meeting News Coverage

VIDEO: Aggressively monitor for change in glaucoma, consider surgery

March 1, 2018
More »